Effect of subcutaneous tissue closure technique in cesarean section on postoperative wound complications in obese Egyptian women

J Matern Fetal Neonatal Med. 2019 Aug;32(15):2452-2459. doi: 10.1080/14767058.2018.1438399. Epub 2018 Feb 20.

Abstract

Subcutaneous tissue closure technique is a wide area of interest for obstetricians who perform cesarean section especially on obese women while many observers studied in an extensive manner postoperative pain and wound cosmetic results.

Aim of the work: The main goal of our work was to display the differences in wound outcome results as regard postoperative wound complications comparing the two widely implemented techniques in subcutaneous tissue closure (interrupted versus continuous methods).

Results: A comparative analysis between continuous and interrupted techniques regarding wound complications (gapping, seroma, erythema, and infection) showing statistical significant differences in all four wound complications presented with p values = .019, .011, .015, and .001, in consecutive order with odds ratio in wound gapping = 5.239, wound seroma OR = 9.429, wound erythema OR = 3.709, and wound infection OR = 6.136.

Conclusions: Subcutaneous wound closure using interrupted technique of suturing in obese patients is superior to continuous technique as regard wound complications. Clinical trials.gov ID Identifier (NCT03354078).

Keywords: Subcutaneous; erythema; seroma; wound gapping; wound infection.

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Cesarean Section / adverse effects
  • Cesarean Section / methods*
  • Female
  • Humans
  • Obesity / complications*
  • Pregnancy
  • Pregnancy Complications
  • Subcutaneous Fat / surgery
  • Surgical Wound Dehiscence / etiology
  • Surgical Wound Dehiscence / prevention & control*
  • Surgical Wound Infection / etiology
  • Surgical Wound Infection / prevention & control*
  • Suture Techniques / statistics & numerical data*

Associated data

  • ClinicalTrials.gov/NCT03354078